Burning Rock Biotech (BNR) Cash from Financing Activities (2019 - 2025)
Burning Rock Biotech (BNR) recorded quarterly Cash from Financing Activities of -$14000.0 in Q4 2025, down 105.02% quarter-over-quarter from $279000.0 in Q2 2025, and down 40.0% on a YoY basis from -$23333.3 in Q4 2024.
Burning Rock Biotech (BNR) Cash from Financing Activities (2019 - 2025) Analysis & Trends
Burning Rock Biotech's Cash from Financing Activities history runs 7 years deep, the most recent figure standing at -$14000.0 for Q4 2025.
- In Q4 2025, Cash from Financing Activities fell 40.0% year-over-year to -$14000.0; the TTM figure through Dec 2025 stood at $255279.1 (up 188.31% YoY), while the FY2025 annual figure was $272000.0, up 2820.0% from the prior year.
- Cash from Financing Activities was -$14000.0 for Q4 2025 at Burning Rock Biotech, down from $279000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $279000.0 in Q2 2025 to a low of -$12.5 million in Q4 2022.
- Historically, Cash from Financing Activities has averaged -$2.3 million across 5 years, with a median of -$375000.0 in 2022.
- The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities sank 1577.07% in 2023, then jumped 100.0% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at -$1.1 million in 2021, then slumped by 1073.99% to -$12.5 million in 2022, then soared by 97.85% to -$269000.0 in 2023, then jumped by 96.28% to -$10000.0 in 2024, then slumped by 40.0% to -$14000.0 in 2025.
- The last three Cash from Financing Activities figures came in at -$14000.0 (Q4 2025), $279000.0 (Q2 2025), and -$10000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,149.49 Bn | 29,149.03 Bn | 1.11 Bn | -213.00 Mn |
| 2 | Thermo Fisher Scientific | 174.37 Bn | 171.12 Bn | 7.74 Bn | 1.09 Bn |
| 3 | Danaher | 127.33 Bn | 121.64 Bn | 3.59 Bn | 46.00 Mn |
| 4 | Idexx Laboratories | 44.68 Bn | 44.48 Bn | 722.74 Mn | -211.43 Mn |
| 5 | Agilent Technologies | 36.54 Bn | 34.74 Bn | 990.00 Mn | -144.00 Mn |
| 6 | Iqvia Holdings | 30.51 Bn | 28.53 Bn | 1.36 Bn | -433.00 Mn |
| 7 | Natera | 30.00 Bn | 28.90 Bn | 696.04 Mn | 3.76 Mn |
| 8 | Illumina | 24.61 Bn | 23.45 Bn | 721.00 Mn | -251.00 Mn |
| 9 | Mettler Toledo International | 22.91 Bn | 22.85 Bn | 555.82 Mn | -114.33 Mn |
| 10 | Burning Rock Biotech | 23.07 Mn | -44.76 Mn | 14.10 Mn | -14,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -14,000.00 |
| Dec 31, 2025 | -14,000.00 |
| Jun 30, 2025 | 279,000.00 |
| Jun 30, 2025 | 279,000.00 |
| Dec 31, 2024 | -10,000.00 |
| Dec 31, 2024 | -10,000.00 |
| Sep 30, 2024 | 279.06 |
| Sep 30, 2024 | 279.06 |
| Mar 31, 2024 | -10,348.62 |
| Mar 31, 2024 | -10,348.62 |
| Dec 31, 2023 | -269,000.00 |
| Dec 31, 2023 | -269,000.00 |
| Sep 30, 2023 | -6.29 Mn |
| Sep 30, 2023 | -6.29 Mn |
| Jun 30, 2023 | -138,000.00 |
| Jun 30, 2023 | -138,000.00 |
| Mar 31, 2023 | -5,000.00 |
| Mar 31, 2023 | -5,000.00 |
| Dec 31, 2022 | -12.50 Mn |
| Dec 31, 2022 | -12.50 Mn |